How Is a Port Study Done to Check for Blockage?

A port study for blockage is a contrast-based imaging procedure in which a radiologist or nurse accesses your implanted port with a special needle, injects contrast dye through the catheter, and takes real-time X-ray images (fluoroscopy) to see whether fluid flows freely or gets held up somewhere along the line. The medical term you may hear is a “linogram” or “catheter contrast study.” The whole process usually takes less than half an hour, requires no general anesthesia, and gives your care team a clear picture of whether the problem is a blood clot, a fibrin sheath wrapped around the catheter tip, a mechanical kink, or something else entirely.

Why Ports Block in the First Place

Understanding what causes a blockage helps make sense of what the study is actually looking for. The most common culprit is thrombotic obstruction, meaning a clot or clot-like material has formed inside or around the catheter. Your body recognizes the catheter as a foreign object and kicks off its clotting response almost immediately after the port is placed. Over time, proteins coat the outside of the catheter and form a sleeve-like structure called a fibrin sheath. Up to half of patients with long-term central venous catheters develop fibrin sheath-related dysfunction.¹ A fibrin sheath can act like a one-way valve: fluid goes in without much trouble, but you can’t pull blood back out. That’s often the first clue that something is wrong.

Beyond fibrin sheaths, a straightforward blood clot can form inside the catheter lumen itself, completely blocking flow in both directions. Drug precipitates are another possibility, though much less common. Certain medications can crystallize inside the line if they mix with incompatible fluids. In one documented case, phenytoin precipitated when it came into contact with an acidic dextrose solution, completely plugging the port until the blockage was dissolved with a sodium bicarbonate flush.²

Mechanical problems round out the list. The catheter can fracture, migrate out of position, or get pinched between the collarbone and first rib in a phenomenon called pinch-off syndrome. Any of these will cause the port to malfunction, and the contrast study is how clinicians figure out which category of problem they’re dealing with.

What Happens During the Procedure

If your port isn’t drawing blood or infusing properly, your oncology team or interventional radiology department will schedule the study. You’ll lie on a fluoroscopy table, and the skin over your port is cleaned and numbed with a local anesthetic. A Huber needle, which is a special non-coring needle designed specifically for ports, is inserted through the skin into the port’s reservoir. The clinician first tries to aspirate (pull back) blood. If blood returns easily, that’s actually a good sign that the line isn’t fully blocked, though partial obstructions can still exist.

Next, contrast dye is injected through the port while the fluoroscopy machine captures live X-ray images on a monitor. The radiologist watches the dye travel through the catheter and into the vein. In a healthy, unobstructed port, the contrast flows smoothly out the catheter tip and disperses into the bloodstream. When something is wrong, the images tell a specific story depending on the type of blockage.

Reading the Images

A fibrin sheath shows up as contrast dye tracking backward along the outside of the catheter wall instead of flowing freely from the tip. The dye essentially squeezes between the sheath and the catheter, creating a visible trail that runs in the wrong direction. The length of this retrograde trail tells the radiologist how far the sheath extends.³ An intraluminal clot, by contrast, shows up as a complete stop: the dye simply won’t advance past a certain point inside the catheter. A catheter fracture is usually visible on a plain chest X-ray before contrast is even injected, appearing as a break in the catheter line. In some cases, the broken fragment migrates into the heart or a pulmonary artery, which shows up clearly on imaging.⁴

Migration without fracture is another finding. The catheter tip may have shifted from its intended position near the junction of the superior vena cava and the right atrium to some other vessel. In one reported case, severe coughing pushed a catheter tip all the way into the axillary vein.⁵ A study of nearly 300 patients found a migration rate of about 2.3%, with lung cancer and male sex identified as significant risk factors.⁶

When the Study Is Skipped

Here’s something that surprises many patients: a full contrast study isn’t always performed. When a port won’t flush or draw blood and the clinical picture strongly suggests a simple clot, many centers skip directly to treatment with a clot-dissolving drug. This approach is common enough that one major review described it as standard practice in the United States.⁷ The reasoning is straightforward: the treatment (a small dose of alteplase left to sit in the catheter) carries very low risk, and if it works, both the diagnosis and the fix happen in one step. The contrast study is reserved for cases where the thrombolytic doesn’t restore function, where mechanical damage is suspected, or where the clinical picture is ambiguous.

A plain chest X-ray is often the first imaging step before anything else. It can quickly reveal catheter fracture, gross migration, or pinch-off syndrome without needing contrast at all. Pinch-off syndrome, where the catheter gets compressed between the clavicle and first rib, can progress from intermittent narrowing to complete fracture if left unchecked.⁸ When a chest X-ray shows catheter fracture with a missing fragment, the situation becomes urgent because the loose piece can embolize to the heart or lungs.⁹

Treating a Thrombotic Blockage

If the blockage turns out to be a clot or fibrin sheath, the first-line treatment is alteplase, a clot-dissolving enzyme. A small dose, typically 2 mg in 2 mL, is instilled directly into the catheter and left to sit. The drug works by activating the body’s own clot-breakdown system right at the site of the obstruction. After a dwell time of 30 to 120 minutes, the nurse attempts to aspirate and flush the line. In the large COOL trial, flow was restored in about half of catheters within 30 minutes of the first dose, and in roughly 87% after a second dose was given if needed.¹⁰ That trial also found 30-day patency (meaning the line stayed open) was about 74%, so a minority of ports re-occlude within a month.

Overall clearance rates with alteplase across multiple studies fall in the range of 83% to 95%, with pediatric patients responding at least as well as adults.¹¹ In one series of 50 occluded chest ports, every single port was restored with alteplase (some requiring a double dose), and no adverse events were recorded.¹² These numbers are reassuring, but they apply specifically to thrombotic blockages. If the problem is mechanical or caused by drug precipitation, alteplase won’t help.

What If Alteplase Doesn’t Work

When thrombolytic therapy fails, interventional radiology gets involved with more hands-on approaches. Several techniques exist for dealing with stubborn fibrin sheaths. Balloon angioplasty can be threaded through or alongside the catheter to physically break up the sheath. A snare device can strip the sheath off the catheter. The catheter can be exchanged over a guidewire, replacing the old one while reusing the existing port pocket and venous access point. In one review, about half of port occlusion salvage procedures involved fibrin sheath stripping, with the remainder split between over-the-wire catheter exchanges and complete replacements at a new site.¹³

None of these mechanical approaches is a permanent fix for fibrin sheaths. Balloon disruption and snaring risk releasing sheath fragments into the bloodstream, which can travel to the lungs. A catheter exchange over a guidewire doesn’t actually remove the fibrin sheath from the vessel wall, so the new catheter may malfunction again as the old sheath grows to cover the new tip. Guidewire disruption of the sheath only treats the portion right at the catheter tip, making it a short-term solution at best.¹ When a port has been salvaged and re-occluded multiple times, the decision often comes down to removing it entirely and placing a new port at a different site.

Mechanical Problems That Mimic Blockage

Not every “blocked” port is actually blocked by a clot. Pinch-off syndrome can cause intermittent obstruction that depends on your arm or shoulder position. The catheter gets physically compressed in the tight space between the clavicle and the first rib, so the port may flush fine when your arm is at your side but fail when your arm is raised. Over time, the repeated compression can weaken and fracture the catheter. Ports placed via the subclavian vein are most susceptible, and this is one reason many centers now favor the internal jugular vein for port insertion.¹⁴

Catheter malposition is another mechanical cause. Anatomical variations, left-sided insertion, and changes in body habitus can all contribute to the catheter tip ending up in an unfavorable position.¹⁵ A malpositioned tip doesn’t necessarily mean the catheter is fractured or clotted. It might just be sitting against a vessel wall, which blocks aspiration but still allows infusion. The contrast study helps distinguish this from true occlusion because the dye will flow freely once the catheter tip position is identified.

Deep Vein Thrombosis Around the Port

A port study checks the catheter itself, but blockage can also develop in the vein surrounding the catheter. This is catheter-related deep vein thrombosis, a separate and potentially more serious problem. In a study of nearly 300 breast cancer patients, about 6% developed an upper-extremity DVT on the same side as their port. The risk was significantly higher with arm-placed ports (roughly 10%) compared to chest-placed ports (about 2%).¹⁶ If your port is working poorly and a linogram doesn’t show an obvious catheter problem, your team may order a duplex ultrasound of the arm and chest veins to check for surrounding clot. This is a different test from the port study and uses sound waves rather than contrast dye.

Catheter-related thrombosis in the surrounding vein was found in roughly 1.7% of patients in a large audit of over 400 port placements, while persistent withdrawal occlusion (where the port won’t draw blood but still infuses) occurred in about 3.4%.¹⁷ Withdrawal occlusion is the most common day-to-day complaint patients and nurses deal with, and it doesn’t always signal a serious problem. Sometimes repositioning, deep breathing, or having the patient raise their arms is enough to restore blood return.

Keeping the Port Open After Treatment

Once a blockage has been cleared, the question becomes how to keep it from coming back. Routine flushing is the main preventive strategy, but there’s been genuine debate about whether heparin flushes are necessary or whether plain saline does the job just as well. A systematic review pooling data from eight studies found no clear advantage for heparin over normal saline in maintaining catheter patency.¹⁸ A second meta-analysis focused specifically on implanted ports in cancer patients reached the same conclusion, recommending that saline can safely replace heparin at concentrations of 50 to 100 units per milliliter.¹⁹

This matters because heparin, while generally safe in these tiny doses, carries a small risk of heparin-induced thrombocytopenia, a paradoxical immune reaction that can actually cause dangerous clotting. If saline works equally well for keeping the line open, there’s little reason to accept that extra risk. Many institutions have already switched to saline-only flushing protocols for ports, though practice varies. If your port has had recurrent occlusions, your team may still prefer heparin or increase your flushing frequency.

How Port Location Affects Blockage Risk

Where the port is placed on your body influences which complications are more likely. Subclavian vein insertion, where the catheter passes under the collarbone, carries the unique risk of pinch-off syndrome. Internal jugular vein insertion avoids that pinch point but requires tunneling the catheter a bit further under the skin. Arm ports, placed in the upper arm with the catheter threaded into a central vein, avoid the chest entirely but carry a higher DVT risk as noted earlier.

The catheter material and size also play a role. In the Taiwanese migration study, all seven cases of port migration occurred with a smaller, silicone-based catheter rather than a larger alternative, and the migration rate for that specific device was nearly 7%.⁶ Silicone is softer and more flexible than polyurethane, which may make it more prone to shifting. These are details patients rarely get to choose, but they’re worth asking about if you’ve had previous port complications and are having a new one placed.

When a Port Needs to Come Out

Sometimes the answer to a blockage isn’t salvage but removal. Repeated occlusions that keep returning despite thrombolytic treatment, confirmed catheter fracture with an embolized fragment, port pocket infection, and catheter-related bloodstream infection are all common reasons for port removal. Fracture with embolization is treated as an emergency: the loose fragment must be retrieved, usually by an interventional radiologist using a snare device threaded through a femoral vein, before a new port can be placed elsewhere.

For patients in the middle of chemotherapy, losing a port is disruptive but not catastrophic. A new port can often be placed on the opposite side within a few days. In the interim, treatment can continue through a peripheral IV or a temporary central line if needed. The decision to remove versus salvage depends on how far along you are in your treatment plan, the nature of the complication, and whether the port site is infected. Infection in the port pocket or bloodstream almost always means the entire device has to come out, because bacteria colonize the hardware itself and antibiotics alone rarely sterilize it.